| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.97 | 0.001 | 0.97 | Estrogen agonist | 0.076 0.024 DBMET03760 0.042 0.041 DBMET03762 | ||
| 0.888 | 0.004 | 0.888 | Antiadrenergic | |||
| 0.887 | 0.004 | 0.887 | Adrenaline antagonist | |||
| 0.843 | 0.003 | 0.843 | Immunosuppressant | 0.385 0.07 DBMET03760 0.568 0.017 DBMET03762 | ||
| 0.825 | 0.002 | 0.825 | Adrenaline uptake inhibitor | 0.212 0.005 DBMET03760 0.108 0.017 DBMET03762 0.105 0.017 DBMET03761 | ||
| 0.805 | 0.003 | 0.805 | 5 Hydroxytryptamine uptake inhibitor | 0.115 0.022 DBMET03760 | ||
| 0.721 | 0.001 | 0.721 | Peptidyltransferase inhibitor | |||
| 0.521 | 0.008 | 0.591 | Sigma receptor agonist | 0.591 0.005 DBMET03760 0.494 0.01 DBMET03762 0.512 0.009 DBMET03761 | DBMET03760 | |
| 0.437 | 0.012 | 0.437 | Anesthetic general | 0.38 0.019 DBMET03760 0.365 0.021 DBMET03762 0.174 0.092 DBMET03761 | ||
| 0.454 | 0.049 | 0.625 | 5 Hydroxytryptamine release inhibitor | 0.625 0.008 DBMET03760 0.61 0.01 DBMET03762 0.462 0.046 DBMET03761 | DBMET03760 | |
| 0.395 | 0.004 | 0.395 | Dopamine uptake inhibitor | 0.155 0.009 DBMET03760 0.088 0.022 DBMET03762 0.073 0.029 DBMET03761 | ||
| 0.417 | 0.043 | 0.417 | Streptokinase A inhibitor | 0.386 0.051 DBMET03760 0.221 0.121 DBMET03762 | ||
| 0.368 | 0.021 | 0.477 | 5 Hydroxytryptamine uptake stimulant | 0.477 0.005 DBMET03760 0.456 0.007 DBMET03762 0.366 0.021 DBMET03761 | DBMET03760 | |
| 0.403 | 0.06 | 0.493 | GABA C receptor rho-3 antagonist | 0.493 0.028 DBMET03760 0.441 0.045 DBMET03762 0.407 0.059 DBMET03761 | DBMET03760 | |
| 0.355 | 0.047 | 0.447 | Calcium channel activator | 0.447 0.012 DBMET03760 0.426 0.017 DBMET03762 0.356 0.046 DBMET03761 | DBMET03760 | |
| 0.286 | 0.011 | 0.555 | Cystathionine beta-synthase inhibitor | 0.501 0.004 DBMET03760 0.555 0.003 DBMET03762 0.294 0.01 DBMET03761 | DBMET03762 | |
| 0.266 | 0.004 | 0.266 | Thioredoxin inhibitor | |||
| 0.368 | 0.13 | 0.368 | Apoptosis agonist | |||
| 0.246 | 0.009 | 0.246 | Alpha 2a adrenoreceptor antagonist | |||
| 0.228 | 0.014 | 0.228 | Alpha 2 adrenoreceptor antagonist | |||
| 0.229 | 0.022 | 0.229 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.226 | 0.032 | 0.408 | Succinate dehydrogenase inhibitor | 0.35 0.005 DBMET03760 0.408 0.004 DBMET03762 0.233 0.029 DBMET03761 | DBMET03762 | |
| 0.191 | 0.009 | 0.281 | Electrolyte absorption antagonist | 0.276 0.004 DBMET03760 0.281 0.004 DBMET03762 0.153 0.018 DBMET03761 | DBMET03762 | |
| 0.253 | 0.071 | 0.29 | 5 Hydroxytryptamine 1E antagonist | 0.29 0.037 DBMET03760 0.225 0.102 DBMET03762 0.251 0.073 DBMET03761 | DBMET03760 | |
| 0.186 | 0.005 | 0.186 | Androgen agonist | 0.102 0.014 DBMET03760 0.079 0.024 DBMET03762 0.053 0.052 DBMET03761 | ||
| 0.19 | 0.01 | 0.19 | Adenosine A3 receptor antagonist | 0.088 0.034 DBMET03760 | ||
| 0.281 | 0.103 | 0.573 | Cholesterol antagonist | 0.538 0.027 DBMET03760 0.573 0.022 DBMET03762 0.286 0.1 DBMET03761 | DBMET03762 | |
| 0.225 | 0.055 | 0.35 | Non-steroidal antiinflammatory agent | 0.238 0.048 DBMET03760 0.35 0.02 DBMET03762 | DBMET03762 | |
| 0.173 | 0.006 | 0.173 | Thioredoxin reductase inhibitor | |||
| 0.255 | 0.094 | 0.275 | Ca(v)3.3 blocker | 0.275 0.067 DBMET03760 0.202 0.189 DBMET03762 0.259 0.087 DBMET03761 | DBMET03760 | |
| 0.186 | 0.031 | 0.186 | Aldehyde dehydrogenase inhibitor | 0.161 0.041 DBMET03760 0.163 0.04 DBMET03762 | ||
| 0.216 | 0.065 | 0.278 | Nitric-oxide synthase stimulant | 0.278 0.018 DBMET03760 0.247 0.034 DBMET03762 0.219 0.062 DBMET03761 | DBMET03760 | |
| 0.238 | 0.095 | 0.478 | 5 Hydroxytryptamine release stimulant | 0.478 0.031 DBMET03760 0.282 0.076 DBMET03762 0.219 0.106 DBMET03761 | DBMET03760 | |
| 0.163 | 0.02 | 0.187 | Ca2+-transporting ATPase inhibitor | 0.187 0.005 DBMET03760 0.183 0.005 DBMET03762 0.163 0.02 DBMET03761 | DBMET03760 | |
| 0.179 | 0.038 | 0.179 | Anesthetic local | 0.12 0.067 DBMET03760 0.128 0.061 DBMET03762 | ||
| 0.149 | 0.012 | 0.226 | Lanosterol 14 alpha demethylase inhibitor | 0.226 0.004 DBMET03760 0.184 0.005 DBMET03762 0.146 0.013 DBMET03761 | DBMET03760 | |
| 0.168 | 0.033 | 0.168 | Alpha adrenoreceptor antagonist | |||
| 0.14 | 0.007 | 0.14 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.165 | 0.039 | 0.165 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.218 | 0.096 | 0.603 | Aldehyde oxidase inhibitor | 0.603 0.019 DBMET03760 0.577 0.022 DBMET03762 0.22 0.095 DBMET03761 | DBMET03760 | |
| 0.144 | 0.028 | 0.35 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.305 0.006 DBMET03760 0.35 0.004 DBMET03762 0.15 0.026 DBMET03761 | DBMET03762 | |
| 0.212 | 0.099 | 0.279 | Neuropeptide Y2 antagonist | 0.279 0.031 DBMET03760 0.249 0.058 DBMET03762 0.212 0.099 DBMET03761 | DBMET03760 | |
| 0.308 | 0.203 | 0.391 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.391 0.109 DBMET03760 0.306 0.205 DBMET03762 0.311 0.198 DBMET03761 | DBMET03760 | |
| 0.189 | 0.084 | 0.198 | 5 Hydroxytryptamine 3E antagonist | 0.198 0.065 DBMET03760 0.184 0.096 DBMET03761 | DBMET03760 | |
| 0.129 | 0.029 | 0.132 | Androgen antagonist | 0.132 0.028 DBMET03760 0.083 0.062 DBMET03762 | DBMET03760 | |
| 0.148 | 0.058 | 0.283 | Nav1.2 sodium channel blocker | 0.283 0.017 DBMET03760 0.176 0.044 DBMET03762 0.146 0.059 DBMET03761 | DBMET03760 | |
| 0.099 | 0.009 | 0.122 | Exportin-1 inhibitor | 0.122 0.004 DBMET03760 0.113 0.005 DBMET03762 0.1 0.009 DBMET03761 | DBMET03760 | |
| 0.183 | 0.094 | 0.276 | Neurotrophic factor enhancer | 0.276 0.026 DBMET03760 0.253 0.037 DBMET03762 0.184 0.093 DBMET03761 | DBMET03760 | |
| 0.243 | 0.155 | 0.335 | Calpain 2 inhibitor | 0.335 0.094 DBMET03760 0.255 0.146 DBMET03762 0.263 0.14 DBMET03761 | DBMET03760 | |
| 0.148 | 0.061 | 0.148 | Neurotrophic factor | |||
| 0.208 | 0.121 | 0.316 | Tyrosine 3 hydroxylase inhibitor | 0.295 0.036 DBMET03760 0.316 0.026 DBMET03762 0.209 0.12 DBMET03761 | DBMET03762 | |
| 0.158 | 0.079 | 0.212 | Arachidonic acid antagonist | 0.208 0.026 DBMET03760 0.212 0.022 DBMET03762 0.159 0.077 DBMET03761 | DBMET03762 | |
| 0.081 | 0.003 | 0.1 | Alpha 2d adrenoreceptor agonist | 0.1 0.003 DBMET03760 0.055 0.004 DBMET03762 0.073 0.004 DBMET03761 | DBMET03760 | |
| 0.09 | 0.016 | 0.17 | Glutamate (mGluR6) antagonist | 0.144 0.004 DBMET03760 0.17 0.003 DBMET03762 0.092 0.014 DBMET03761 | DBMET03762 | |
| 0.159 | 0.086 | 0.253 | ATPase inhibitor | 0.253 0.013 DBMET03760 0.224 0.022 DBMET03762 0.159 0.086 DBMET03761 | DBMET03760 | |
| 0.114 | 0.044 | 0.243 | HIV-1 integrase (Overall Integration) inhibitor | 0.228 0.007 DBMET03760 0.243 0.005 DBMET03762 0.113 0.044 DBMET03761 | DBMET03762 | |
| 0.074 | 0.005 | 0.325 | Glutamate (mGluR3) antagonist | 0.296 0.003 DBMET03760 0.325 0.002 DBMET03762 0.077 0.005 DBMET03761 | DBMET03762 | |
| 0.132 | 0.067 | 0.357 | Alpha-N-acetylglucosaminidase inhibitor | 0.292 0.017 DBMET03760 0.357 0.011 DBMET03762 0.14 0.061 DBMET03761 | DBMET03762 | |
| 0.08 | 0.015 | 0.119 | Calcium channel P-type blocker | 0.119 0.004 DBMET03760 0.083 0.012 DBMET03762 0.077 0.018 DBMET03761 | DBMET03760 | |
| 0.126 | 0.068 | 0.233 | Nav1.3 sodium channel blocker | 0.233 0.017 DBMET03760 0.153 0.046 DBMET03762 0.124 0.07 DBMET03761 | DBMET03760 | |
| 0.061 | 0.005 | 0.061 | Cathepsin F inhibitor | |||
| 0.098 | 0.048 | 0.137 | Histamine N-methyltransferase inhibitor | 0.137 0.019 DBMET03760 0.105 0.041 DBMET03762 0.091 0.054 DBMET03761 | DBMET03760 | |
| 0.055 | 0.007 | 0.086 | Glutamate (mGluR8) antagonist | 0.081 0.003 DBMET03760 0.086 0.003 DBMET03762 0.055 0.007 DBMET03761 | DBMET03762 | |
| 0.104 | 0.055 | 0.181 | Sphingomyelinase inhibitor | 0.181 0.014 DBMET03760 0.128 0.036 DBMET03762 0.104 0.056 DBMET03761 | DBMET03760 | |
| 0.055 | 0.009 | 0.077 | Heme oxygenase inhibitor | 0.077 0.004 DBMET03760 0.059 0.006 DBMET03762 0.053 0.01 DBMET03761 | DBMET03760 | |
| 0.114 | 0.068 | 0.114 | Microtubule formation inhibitor | 0.111 0.073 DBMET03760 0.102 0.087 DBMET03762 | ||
| 0.082 | 0.037 | 0.105 | Vanilloid 4 agonist | 0.105 0.013 DBMET03760 0.094 0.022 DBMET03762 0.082 0.037 DBMET03761 | DBMET03760 | |
| 0.095 | 0.05 | 0.162 | NADH dehydrogenase inhibitor | 0.161 0.015 DBMET03760 0.162 0.015 DBMET03762 0.095 0.05 DBMET03761 | DBMET03762 | |
| 0.068 | 0.025 | 0.068 | Protein 50S ribosomal subunit inhibitor | |||
| 0.052 | 0.016 | 0.056 | Histamine H1 receptor agonist | 0.056 0.012 DBMET03760 0.05 0.018 DBMET03761 | DBMET03760 | |
| 0.103 | 0.07 | 0.165 | DOPA decarboxylase inhibitor | 0.156 0.018 DBMET03760 0.165 0.015 DBMET03762 0.104 0.068 DBMET03761 | DBMET03762 | |
| 0.103 | 0.072 | 0.142 | 5 Hydroxytryptamine 3A agonist | 0.142 0.04 DBMET03760 0.102 0.073 DBMET03761 | DBMET03760 | |
| 0.099 | 0.068 | 0.294 | GABA C receptor agonist | 0.228 0.016 DBMET03760 0.294 0.01 DBMET03762 0.104 0.063 DBMET03761 | DBMET03762 | |
| 0.085 | 0.055 | 0.119 | D-Ala-D-Ala ligase inhibitor | 0.119 0.014 DBMET03760 0.112 0.018 DBMET03762 0.086 0.053 DBMET03761 | DBMET03760 | |
| 0.088 | 0.058 | 0.203 | Ca(v)2.2 blocker | 0.203 0.016 DBMET03760 0.096 0.052 DBMET03762 0.086 0.06 DBMET03761 | DBMET03760 | |
| 0.129 | 0.103 | 0.166 | Pregnane X receptor agonist | 0.166 0.03 DBMET03760 0.145 0.063 DBMET03762 0.127 0.109 DBMET03761 | DBMET03760 | |
| 0.097 | 0.074 | 0.282 | Ferrochelatase inhibitor | 0.235 0.015 DBMET03760 0.282 0.009 DBMET03762 0.104 0.066 DBMET03761 | DBMET03762 | |
| 0.058 | 0.036 | 0.078 | Pregnane X receptor antagonist | 0.078 0.008 DBMET03760 0.072 0.012 DBMET03762 0.058 0.036 DBMET03761 | DBMET03760 | |
| 0.129 | 0.107 | 0.182 | GABA C receptor rho-2 antagonist | 0.182 0.04 DBMET03760 0.157 0.064 DBMET03762 0.131 0.104 DBMET03761 | DBMET03760 | |
| 0.032 | 0.011 | 0.055 | Sodium/glucose cotransporter 2 inhibitor | 0.055 0.005 DBMET03760 0.027 0.017 DBMET03762 | DBMET03760 | |
| 0.043 | 0.025 | 0.071 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.071 0.004 DBMET03760 0.06 0.007 DBMET03762 0.044 0.023 DBMET03761 | DBMET03760 | |
| 0.029 | 0.012 | 0.047 | Sodium/glucose cotransporter inhibitor | 0.047 0.005 DBMET03760 0.026 0.016 DBMET03762 | DBMET03760 | |
| 0.023 | 0.007 | 0.036 | Alpha 2b adrenoreceptor agonist | 0.036 0.004 DBMET03760 0.018 0.015 DBMET03762 0.021 0.009 DBMET03761 | DBMET03760 | |
| 0.072 | 0.056 | 0.113 | CYP2A6 inhibitor | 0.113 0.03 DBMET03760 0.07 0.06 DBMET03761 | DBMET03760 | |
| 0.08 | 0.065 | 0.098 | CC chemokine 5 receptor agonist | 0.098 0.024 DBMET03760 0.079 0.068 DBMET03761 | DBMET03760 | |
| 0.124 | 0.109 | 0.124 | Thiol protease inhibitor | |||
| 0.018 | 0.004 | 0.018 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.014 0.008 DBMET03760 | ||
| 0.1 | 0.088 | 0.13 | Acetylcholine release stimulant | 0.13 0.034 DBMET03760 0.106 0.074 DBMET03762 0.101 0.086 DBMET03761 | DBMET03760 | |
| 0.039 | 0.028 | 0.058 | CF transmembrane conductance regulator antagonist | 0.058 0.005 DBMET03760 0.045 0.014 DBMET03762 0.046 0.013 DBMET03761 | DBMET03760 | |
| 0.072 | 0.061 | 0.127 | GABA B receptor agonist | 0.117 0.008 DBMET03760 0.127 0.006 DBMET03762 0.073 0.059 DBMET03761 | DBMET03762 | |
| 0.085 | 0.075 | 0.125 | Glutamate release inhibitor | 0.125 0.019 DBMET03760 0.116 0.025 DBMET03762 0.084 0.078 DBMET03761 | DBMET03760 | |
| 0.045 | 0.036 | 0.078 | Aldosterone antagonist | 0.078 0.012 DBMET03760 0.059 0.02 DBMET03762 0.046 0.035 DBMET03761 | DBMET03760 | |
| 0.038 | 0.029 | 0.049 | 5 Hydroxytryptamine 2B agonist | 0.049 0.014 DBMET03760 | DBMET03760 | |
| 0.086 | 0.078 | 0.169 | Creatine kinase inhibitor | 0.169 0.017 DBMET03760 0.156 0.022 DBMET03762 0.085 0.078 DBMET03761 | DBMET03760 | |
| 0.052 | 0.045 | 0.089 | Dihydroorotate oxidase inhibitor | 0.089 0.007 DBMET03760 0.068 0.019 DBMET03762 0.053 0.042 DBMET03761 | DBMET03760 | |
| 0.019 | 0.013 | 0.025 | Alpha 2c adrenoreceptor agonist | 0.025 0.006 DBMET03760 | DBMET03760 | |
| 0.037 | 0.031 | 0.08 | GABA uptake inhibitor | 0.08 0.005 DBMET03760 0.072 0.006 DBMET03762 0.037 0.031 DBMET03761 | DBMET03760 | |
| 0.058 | 0.053 | 0.075 | Heme oxygenase stimulant | 0.075 0.02 DBMET03760 0.065 0.033 DBMET03762 0.058 0.052 DBMET03761 | DBMET03760 | |
| 0.024 | 0.02 | 0.037 | Melanocortin 5 antagonist | 0.037 0.013 DBMET03760 0.023 0.021 DBMET03761 | DBMET03760 | |
| 0.135 | 0.131 | 0.198 | 3C-like protease (Human coronavirus) inhibitor | 0.198 0.053 DBMET03760 0.153 0.096 DBMET03762 0.138 0.124 DBMET03761 | DBMET03760 | |
| 0.122 | 0.119 | 0.166 | Neuropeptide Y1 antagonist | 0.166 0.044 DBMET03760 0.137 0.087 DBMET03762 | DBMET03760 | |
| 0.06 | 0.057 | 0.169 | Phosphofructokinase-1 inhibitor | 0.14 0.02 DBMET03760 0.169 0.015 DBMET03762 0.063 0.054 DBMET03761 | DBMET03762 | |
| 0.055 | 0.052 | 0.131 | NMDA receptor glycine site agonist | 0.12 0.009 DBMET03760 0.131 0.006 DBMET03762 0.058 0.048 DBMET03761 | DBMET03762 | |
| 0.055 | 0.053 | 0.078 | Potassium channel intermediate-conductance Ca-activated blocker | 0.078 0.019 DBMET03760 0.063 0.036 DBMET03762 0.055 0.052 DBMET03761 | DBMET03760 | |
| 0.02 | 0.018 | 0.023 | Histone-lysine N-methyltransferase EZH2 inhibitor | 0.023 0.007 DBMET03760 0.02 0.018 DBMET03761 | DBMET03760 | |
| 0.122 | 0.12 | 0.185 | Sphingosine 1-phosphate receptor 5 antagonist | 0.185 0.02 DBMET03760 0.177 0.027 DBMET03762 | DBMET03760 | |
| 0.062 | 0.06 | 0.096 | Glutamate (mGluR7) antagonist | 0.093 0.015 DBMET03760 0.096 0.013 DBMET03762 0.063 0.056 DBMET03761 | DBMET03762 | |
| 0.125 | 0.124 | 0.182 | Melanin inhibitor | 0.182 0.05 DBMET03760 0.172 0.057 DBMET03762 0.126 0.123 DBMET03761 | DBMET03760 | |
| 0.164 | 0.164 | 0.255 | RNA-directed DNA polymerase inhibitor | 0.255 0.046 DBMET03760 0.218 0.076 DBMET03762 0.165 0.163 DBMET03761 | DBMET03760 | |
| 0.084 | 0.083 | 0.155 | UDP-glucose 4-epimerase inhibitor | 0.155 0.027 DBMET03760 0.122 0.042 DBMET03762 0.087 0.079 DBMET03761 | DBMET03760 | |
| 0.046 | 0.046 | 0.121 | Aconitate hydratase inhibitor | 0.092 0.01 DBMET03760 0.121 0.006 DBMET03762 0.049 0.041 DBMET03761 | DBMET03762 | |
| 0.028 | 0.029 | 0.068 | ATP citrate lysase inhibitor | 0.058 0.005 DBMET03760 0.068 0.004 DBMET03762 | DBMET03762 | |
| 0.113 | 0.115 | 0.167 | Sphingosine 1-phosphate receptor 2 antagonist | 0.167 0.023 DBMET03760 0.156 0.034 DBMET03762 | DBMET03760 | |
| 0.034 | 0.037 | 0.059 | Dopamine D5 agonist | 0.059 0.012 DBMET03760 0.04 0.028 DBMET03762 | DBMET03760 | |
| 0.077 | 0.079 | 0.102 | Estrogen-related receptor beta agonist | 0.102 0.022 DBMET03760 0.096 0.029 DBMET03762 | DBMET03760 | |
| 0.093 | 0.097 | 0.186 | Cholesterol synthesis inhibitor | 0.174 0.034 DBMET03760 0.186 0.03 DBMET03762 | DBMET03762 | |
| 0.038 | 0.041 | 0.059 | Nerve growth factor antagonist | 0.059 0.01 DBMET03760 0.048 0.021 DBMET03762 | DBMET03760 | |
| 0.017 | 0.021 | 0.022 | Imidazoline I1 receptor antagonist | 0.022 0.013 DBMET03760 | DBMET03760 | |
| 0.018 | 0.023 | 0.061 | Glutamate (mGluR1a) agonist | 0.05 0.005 DBMET03760 0.061 0.004 DBMET03762 | DBMET03762 | |
| 0.039 | 0.043 | 0.042 | Alpha 1L adrenoreceptor agonist | 0.042 0.034 DBMET03760 | DBMET03760 | |
| 0.072 | 0.077 | 0.167 | NMDA receptor antagonist | 0.167 0.02 DBMET03760 0.146 0.025 DBMET03762 | DBMET03760 | |
| 0.076 | 0.083 | 0.172 | Triose-phosphate isomerase inhibitor | 0.144 0.022 DBMET03760 0.172 0.015 DBMET03762 0.08 0.077 DBMET03761 | DBMET03762 | |
| 0.062 | 0.07 | 0.095 | MDM2 inhibitor | 0.093 0.01 DBMET03760 0.095 0.009 DBMET03762 | DBMET03762 | |
| 0.054 | 0.063 | 0.07 | Corticotropin releasing factor 2 receptor antagonist | 0.07 0.028 DBMET03760 | DBMET03760 | |
| 0.069 | 0.078 | 0.112 | Glycine receptor antagonist | 0.112 0.023 DBMET03760 0.1 0.032 DBMET03762 | DBMET03760 | |
| 0.062 | 0.072 | 0.092 | Phospholipase D inhibitor | 0.092 0.02 DBMET03760 0.084 0.029 DBMET03762 | DBMET03760 | |
| 0.158 | 0.167 | 0.221 | Calpain inhibitor | 0.221 0.093 DBMET03760 0.184 0.13 DBMET03762 0.172 0.146 DBMET03761 | DBMET03760 | |
| 0.027 | 0.037 | 0.063 | Phosphoglycerate kinase inhibitor | 0.063 0.011 DBMET03760 0.046 0.015 DBMET03762 | DBMET03760 | |
| 0.058 | 0.068 | 0.149 | Prostaglandin-E synthase inhibitor | 0.149 0.012 DBMET03760 0.141 0.013 DBMET03762 | DBMET03760 | |
| 0.005 | 0.015 | 0.008 | DNA topoisomerase III inhibitor | 0.008 0.005 DBMET03760 | DBMET03760 | |
| 0.006 | 0.018 | 0.008 | Free fatty acid receptor 2 antagonist | 0.008 0.006 DBMET03760 0.008 0.007 DBMET03762 | DBMET03762 | |
| 0.011 | 0.023 | 0.025 | Thromboxane A2 agonist | 0.021 0.005 DBMET03760 0.025 0.004 DBMET03762 | DBMET03762 | |
| 0.082 | 0.095 | 0.211 | Nav1.1 sodium channel blocker | 0.211 0.017 DBMET03760 0.119 0.049 DBMET03762 | DBMET03760 | |
| 0.027 | 0.04 | 0.048 | Glutamate (mGluR3) agonist | 0.043 0.007 DBMET03760 0.048 0.005 DBMET03762 | DBMET03762 | |
| 0.096 | 0.11 | 0.172 | Cyclooxygenase 3 inhibitor | 0.162 0.039 DBMET03760 0.172 0.032 DBMET03762 | DBMET03762 | |
| 0.063 | 0.077 | 0.131 | GABA aminotransferase inhibitor | 0.12 0.016 DBMET03760 0.131 0.012 DBMET03762 | DBMET03762 | |
| 0.025 | 0.04 | 0.05 | Purinergic P2X7 antagonist | 0.05 0.014 DBMET03760 | DBMET03760 | |
| 0.038 | 0.053 | 0.06 | CC chemokine 4 receptor antagonist | 0.06 0.016 DBMET03760 | DBMET03760 | |
| 0.008 | 0.024 | 0.012 | Purine nucleoside phosphorylase inhibitor | 0.012 0.008 DBMET03760 | DBMET03760 | |
| 0.086 | 0.103 | 0.155 | GABA C receptor antagonist | 0.155 0.027 DBMET03760 0.139 0.037 DBMET03762 | DBMET03760 | |
| 0.044 | 0.061 | 0.064 | Nicotinic alpha3beta2 receptor antagonist | 0.064 0.022 DBMET03760 | DBMET03760 | |
| 0.025 | 0.042 | 0.062 | Free fatty acid receptor 1 antagonist | 0.055 0.007 DBMET03760 0.062 0.005 DBMET03762 | DBMET03762 | |
| 0.028 | 0.046 | 0.076 | Glutamate (mGluR group II) antagonist | 0.076 0.007 DBMET03760 0.072 0.008 DBMET03762 | DBMET03760 | |
| 0.061 | 0.079 | 0.108 | Glycine receptor agonist | 0.102 0.02 DBMET03760 0.108 0.017 DBMET03762 | DBMET03762 | |
| 0.03 | 0.048 | 0.056 | Tryptophan 5 hydroxylase inhibitor | 0.05 0.005 DBMET03760 0.056 0.004 DBMET03762 | DBMET03762 | |
| 0.032 | 0.051 | 0.039 | Histamine H2 receptor agonist | 0.039 0.036 DBMET03760 | DBMET03760 | |
| 0.011 | 0.03 | 0.019 | Alpha 2a adrenoreceptor agonist | 0.019 0.01 DBMET03760 | DBMET03760 | |
| 0.038 | 0.058 | 0.068 | Glucose-6-phosphate isomerase inhibitor | 0.06 0.018 DBMET03760 0.068 0.013 DBMET03762 | DBMET03762 | |
| 0.036 | 0.058 | 0.099 | Glutamate (mGluR group III) antagonist | 0.079 0.008 DBMET03760 0.099 0.005 DBMET03762 | DBMET03762 | |
| 0.03 | 0.052 | 0.036 | Potassium channel Kv1.1 blocker | 0.036 0.03 DBMET03760 | DBMET03760 | |
| 0.019 | 0.042 | 0.041 | Calcium-sensing receptor agonist | 0.041 0.007 DBMET03760 0.039 0.008 DBMET03762 | DBMET03760 | |
| 0.046 | 0.068 | 0.084 | Alpha 2 adrenoreceptor agonist | 0.084 0.021 DBMET03760 | DBMET03760 | |
| 0.031 | 0.054 | 0.13 | NMDA receptor subunit 3B antagonist | 0.13 0.008 DBMET03760 0.13 0.008 DBMET03762 | DBMET03762 | |
| 0.034 | 0.057 | 0.061 | Kainate receptor agonist | 0.053 0.011 DBMET03760 0.061 0.006 DBMET03762 | DBMET03762 | |
| 0.048 | 0.072 | 0.148 | NMDA receptor agonist | 0.12 0.013 DBMET03760 0.148 0.008 DBMET03762 | DBMET03762 | |
| 0.106 | 0.13 | 0.191 | Mannose-6-phosphate isomerase inhibitor | 0.191 0.036 DBMET03760 0.172 0.048 DBMET03762 | DBMET03760 | |
| 0.03 | 0.053 | 0.074 | Liver X receptor alpha agonist | 0.074 0.008 DBMET03760 0.067 0.01 DBMET03762 | DBMET03760 | |
| 0.034 | 0.058 | 0.076 | Dopamine transporter inhibitor | 0.076 0.018 DBMET03760 | DBMET03760 | |
| 0.078 | 0.102 | 0.116 | Anabolic | 0.116 0.044 DBMET03760 0.111 0.049 DBMET03762 | DBMET03760 | |
| 0.015 | 0.04 | 0.075 | Kynurenine 3 monooxygenase inhibitor | 0.056 0.005 DBMET03760 0.075 0.004 DBMET03762 | DBMET03762 | |
| 0.051 | 0.077 | 0.075 | Aryl hydrocarbon receptor antagonist | 0.075 0.031 DBMET03760 | DBMET03760 | |
| 0.033 | 0.059 | 0.045 | Melanocortin antagonist | 0.045 0.035 DBMET03760 | DBMET03760 | |
| 0.02 | 0.048 | 0.047 | Glutamate (mGluR2) antagonist | 0.047 0.009 DBMET03760 0.038 0.013 DBMET03762 | DBMET03760 | |
| 0.021 | 0.048 | 0.031 | Purinergic P2Y15 antagonist | 0.031 0.016 DBMET03760 | DBMET03760 | |
| 0.093 | 0.121 | 0.14 | Cathepsin H inhibitor | 0.14 0.054 DBMET03760 0.126 0.068 DBMET03762 | DBMET03760 | |
| 0.015 | 0.044 | 0.023 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.023 0.009 DBMET03760 | DBMET03760 | |
| 0.03 | 0.06 | 0.053 | Thymidine kinase inhibitor | 0.053 0.017 DBMET03760 0.052 0.017 DBMET03762 | DBMET03760 | |
| 0.035 | 0.066 | 0.051 | Purinergic P2X4 antagonist | 0.051 0.024 DBMET03760 | DBMET03760 | |
| 0.098 | 0.129 | 0.31 | Peroxidase inhibitor | 0.31 0.035 DBMET03760 0.292 0.039 DBMET03762 | DBMET03760 | |
| 0.029 | 0.06 | 0.052 | Glutamate (mGluR8) agonist | 0.045 0.015 DBMET03760 0.052 0.01 DBMET03762 | DBMET03762 | |
| 0.019 | 0.05 | 0.036 | Integrin alpha2beta1 antagonist | 0.033 0.009 DBMET03760 0.036 0.008 DBMET03762 | DBMET03762 | |
| 0.037 | 0.069 | 0.054 | Potassium channel (ATP-sensitive) activator | 0.054 0.022 DBMET03760 | DBMET03760 | |
| 0.038 | 0.07 | 0.057 | Potassium channel (Inward rectifier) activator | 0.057 0.023 DBMET03760 | DBMET03760 | |
| 0.004 | 0.037 | 0.013 | Thromboxane agonist | 0.01 0.008 DBMET03760 0.013 0.005 DBMET03762 | DBMET03762 | |
| 0.011 | 0.044 | 0.04 | Prostaglandin H2 antagonist | 0.035 0.009 DBMET03760 0.04 0.006 DBMET03762 | DBMET03762 | |
| 0.025 | 0.058 | 0.053 | Glutamate (mGluR4) agonist | 0.046 0.012 DBMET03760 0.053 0.01 DBMET03762 | DBMET03762 | |
| 0.015 | 0.049 | 0.052 | Liver X receptor beta antagonist | 0.052 0.008 DBMET03760 0.048 0.009 DBMET03762 | DBMET03760 | |
| 0.114 | 0.149 | 0.172 | Interferon gamma antagonist | 0.172 0.056 DBMET03760 0.166 0.06 DBMET03762 | DBMET03760 | |
| 0.08 | 0.115 | 0.109 | Glutamate (mGluR7) agonist | 0.109 0.044 DBMET03760 0.104 0.051 DBMET03762 | DBMET03760 | |
| 0.014 | 0.049 | 0.033 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.033 0.015 DBMET03760 0.024 0.023 DBMET03762 | DBMET03760 | |
| 0.054 | 0.09 | 0.09 | Nicotinic alpha4beta2 receptor antagonist | 0.09 0.04 DBMET03760 | DBMET03760 | |
| 0.033 | 0.069 | 0.084 | Glutamate (mGluR4) antagonist | 0.069 0.01 DBMET03760 0.084 0.008 DBMET03762 | DBMET03762 | |
| 0.051 | 0.088 | 0.114 | Cathepsin G inhibitor | 0.101 0.033 DBMET03760 0.114 0.029 DBMET03762 | DBMET03762 | |
| 0.021 | 0.057 | 0.03 | Hedgehog signaling activator | 0.03 0.013 DBMET03760 | DBMET03760 | |
| 0.07 | 0.107 | 0.082 | Bromodomain-containing protein 2 inhibitor | 0.082 0.072 DBMET03760 | DBMET03760 | |
| 0.056 | 0.093 | 0.11 | Calcium antagonist | 0.11 0.041 DBMET03760 0.077 0.066 DBMET03762 | DBMET03760 | |
| 0.038 | 0.075 | 0.069 | Alpha-mannosidase inhibitor | 0.069 0.018 DBMET03760 0.066 0.02 DBMET03762 | DBMET03760 | |
| 0.02 | 0.057 | 0.061 | Liver X receptor beta agonist | 0.061 0.008 DBMET03760 0.047 0.012 DBMET03762 | DBMET03760 | |
| 0.041 | 0.078 | 0.086 | Thromboxane synthase inhibitor | 0.076 0.014 DBMET03760 0.086 0.009 DBMET03762 | DBMET03762 | |
| 0.014 | 0.052 | 0.026 | Prostaglandin F2 alpha agonist | 0.023 0.015 DBMET03760 0.026 0.011 DBMET03762 | DBMET03762 | |
| 0.004 | 0.043 | 0.015 | Angiotensin AT1B receptor antagonist | 0.015 0.009 DBMET03760 0.014 0.009 DBMET03762 | DBMET03760 | |
| 0.042 | 0.08 | 0.071 | Botulinum neurotoxin type A inhibitor | 0.071 0.024 DBMET03760 0.065 0.031 DBMET03762 | DBMET03760 | |
| 0.003 | 0.043 | 0.01 | Thyroid hormone beta agonist | 0.008 0.007 DBMET03760 0.01 0.005 DBMET03762 | DBMET03762 | |
| 0.024 | 0.064 | 0.044 | Ceramide glucosyltransferase inhibitor | 0.044 0.012 DBMET03760 0.033 0.03 DBMET03762 | DBMET03760 | |
| 0.093 | 0.133 | 0.138 | Transcription factor STAT6 inhibitor | 0.138 0.034 DBMET03760 0.111 0.078 DBMET03762 | DBMET03760 | |
| 0.058 | 0.1 | 0.076 | Potassium channel (Tandem pore domain) blocker | 0.076 0.045 DBMET03760 | DBMET03760 | |
| 0.012 | 0.053 | 0.017 | CXC chemokine 5 receptor antagonist | 0.017 0.013 DBMET03760 0.017 0.016 DBMET03762 | DBMET03762 | |
| 0.028 | 0.071 | 0.079 | Liver X receptor agonist | 0.079 0.011 DBMET03760 0.054 0.019 DBMET03762 | DBMET03760 | |
| 0.05 | 0.093 | 0.105 | Aminopeptidase I inhibitor | 0.091 0.033 DBMET03760 0.105 0.025 DBMET03762 | DBMET03762 | |
| 0.095 | 0.138 | 0.155 | Sphingosine 1-phosphate receptor 4 antagonist | 0.155 0.029 DBMET03760 0.143 0.04 DBMET03762 | DBMET03760 | |
| 0.059 | 0.103 | 0.108 | Myeloperoxidase inhibitor | 0.108 0.027 DBMET03760 0.081 0.065 DBMET03762 | DBMET03760 | |
| 0.011 | 0.056 | 0.035 | NMDA receptor glycine site antagonist | 0.033 0.011 DBMET03760 0.035 0.01 DBMET03762 | DBMET03762 | |
| 0.04 | 0.084 | 0.077 | Sphingosine 1-phosphate receptor 3 antagonist | 0.077 0.019 DBMET03760 0.067 0.029 DBMET03762 | DBMET03760 | |
| 0.088 | 0.133 | 0.167 | Interleukin 8 antagonist | 0.167 0.024 DBMET03760 0.161 0.028 DBMET03762 | DBMET03760 | |
| 0.125 | 0.17 | 0.196 | Phospholipase C inhibitor | 0.194 0.048 DBMET03760 0.196 0.047 DBMET03762 | DBMET03762 | |
| 0.018 | 0.063 | 0.054 | Fumarate hydratase inhibitor | 0.04 0.018 DBMET03760 0.054 0.012 DBMET03762 | DBMET03762 | |
| 0.016 | 0.062 | 0.038 | Thyroid hormone agonist | 0.031 0.011 DBMET03760 0.038 0.007 DBMET03762 | DBMET03762 | |
| 0.03 | 0.076 | 0.055 | Adenylate cyclase 1 inhibitor | 0.055 0.021 DBMET03760 | DBMET03760 | |
| 0.02 | 0.066 | 0.096 | NMDA receptor subunit 3A antagonist | 0.089 0.01 DBMET03760 0.096 0.009 DBMET03762 | DBMET03762 | |
| 0.062 | 0.108 | 0.115 | Glutathione S-transferase inhibitor | 0.107 0.031 DBMET03760 0.115 0.025 DBMET03762 | DBMET03762 | |
| 0.041 | 0.087 | 0.086 | Cannabinoid CB1 receptor antagonist | 0.086 0.022 DBMET03760 | DBMET03760 | |
| 0.02 | 0.067 | 0.027 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.027 0.016 DBMET03760 | DBMET03760 | |
| 0.024 | 0.072 | 0.049 | Integrin alpha2 antagonist | 0.045 0.015 DBMET03760 0.049 0.012 DBMET03762 | DBMET03762 | |
| 0.017 | 0.065 | 0.065 | Complement C3a chemotactic receptor antagonist | 0.053 0.025 DBMET03760 0.065 0.019 DBMET03762 | DBMET03762 | |
| 0.122 | 0.172 | 0.154 | Heat shock protein 70 antagonist | 0.154 0.038 DBMET03760 0.15 0.046 DBMET03762 | DBMET03760 | |
| 0.009 | 0.058 | 0.02 | Thyroid hormone alpha agonist | 0.016 0.011 DBMET03760 0.02 0.007 DBMET03762 | DBMET03762 | |
| 0.035 | 0.085 | 0.069 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.069 0.022 DBMET03760 | DBMET03760 | |
| 0.04 | 0.091 | 0.126 | Sphingosine 1-phosphate receptor 4 agonist | 0.12 0.017 DBMET03760 0.126 0.014 DBMET03762 | DBMET03762 | |
| 0.051 | 0.102 | 0.12 | Glutamate dehydrogenase inhibitor | 0.096 0.033 DBMET03760 0.12 0.023 DBMET03762 | DBMET03762 | |
| 0.021 | 0.074 | 0.037 | Alpha 1d adrenoreceptor agonist | 0.037 0.029 DBMET03760 | DBMET03760 | |
| 0.028 | 0.081 | 0.098 | Thromboxane antagonist | 0.085 0.017 DBMET03760 0.098 0.012 DBMET03762 | DBMET03762 | |
| 0.012 | 0.066 | 0.066 | Glucagon receptor antagonist | 0.053 0.009 DBMET03760 0.066 0.007 DBMET03762 | DBMET03762 | |
| 0.071 | 0.124 | 0.123 | GABA C receptor rho-1 antagonist | 0.123 0.037 DBMET03760 0.114 0.046 DBMET03762 | DBMET03760 | |
| 0.035 | 0.089 | 0.096 | Carbamoyl phosphate synthetase inhibitor | 0.079 0.029 DBMET03760 0.096 0.022 DBMET03762 | DBMET03762 | |
| 0.016 | 0.07 | 0.031 | Glutamate (mGluR1) agonist | 0.028 0.012 DBMET03760 0.031 0.009 DBMET03762 | DBMET03762 | |
| 0.004 | 0.058 | 0.011 | Glutamate (mGluR6) agonist | 0.011 0.01 DBMET03762 | DBMET03762 | |
| 0.008 | 0.062 | 0.018 | Nicotinic acid receptor 1 antagonist | 0.018 0.012 DBMET03760 | DBMET03760 | |
| 0.005 | 0.06 | 0.022 | G-protein-coupled receptor 120 agonist | 0.017 0.012 DBMET03760 0.022 0.008 DBMET03762 | DBMET03762 | |
| 0.024 | 0.08 | 0.087 | Thromboxane A2 antagonist | 0.077 0.017 DBMET03760 0.087 0.011 DBMET03762 | DBMET03762 | |
| 0.012 | 0.069 | 0.029 | Lysine carboxypeptidase inhibitor | 0.024 0.023 DBMET03760 0.029 0.017 DBMET03762 | DBMET03762 | |
| 0.07 | 0.126 | 0.114 | Bile acid receptor antagonist | 0.111 0.03 DBMET03760 0.114 0.026 DBMET03762 | DBMET03762 | |
| 0.041 | 0.097 | 0.077 | Purinergic P2X1 antagonist | 0.077 0.027 DBMET03760 0.069 0.033 DBMET03762 | DBMET03760 | |
| 0.027 | 0.084 | 0.088 | Glutamate (mGluR group III) agonist | 0.073 0.014 DBMET03760 0.088 0.012 DBMET03762 | DBMET03762 | |
| 0.025 | 0.082 | 0.056 | Mannosidase inhibitor | 0.056 0.019 DBMET03760 0.053 0.023 DBMET03762 | DBMET03760 | |
| 0.017 | 0.075 | 0.054 | Farnesoid X receptor agonist | 0.054 0.013 DBMET03760 0.047 0.017 DBMET03762 | DBMET03760 | |
| 0.017 | 0.075 | 0.025 | Thymidine phosphorylase inhibitor | 0.025 0.02 DBMET03760 | DBMET03760 | |
| 0.011 | 0.069 | 0.032 | Uridine phosphorylase inhibitor | 0.032 0.016 DBMET03760 | DBMET03760 | |
| 0.004 | 0.063 | 0.012 | Integrin beta2 antagonist | 0.011 0.01 DBMET03760 0.012 0.009 DBMET03762 | DBMET03762 | |
| 0.176 | 0.235 | 0.426 | Histamine release inhibitor | 0.421 0.065 DBMET03760 0.426 0.062 DBMET03762 | DBMET03762 | |
| 0.022 | 0.082 | 0.061 | Angiotensin AT1 receptor antagonist | 0.051 0.016 DBMET03760 0.061 0.005 DBMET03762 | DBMET03762 | |
| 0.068 | 0.129 | 0.092 | Interleukin 1 beta converting enzyme inhibitor | 0.092 0.069 DBMET03762 | DBMET03762 | |
| 0.068 | 0.129 | 0.122 | Alpha 2b adrenoreceptor antagonist | 0.122 0.057 DBMET03760 | DBMET03760 | |
| 0.033 | 0.095 | 0.099 | Biliverdin reductase inhibitor | 0.08 0.026 DBMET03760 0.099 0.019 DBMET03762 | DBMET03762 | |
| 0.037 | 0.099 | 0.055 | Calcium channel T-type blocker | 0.055 0.046 DBMET03760 | DBMET03760 | |
| 0.053 | 0.117 | 0.071 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.071 0.057 DBMET03760 | DBMET03760 | |
| 0.014 | 0.079 | 0.033 | LFA antagonist | 0.032 0.013 DBMET03760 0.033 0.013 DBMET03762 | DBMET03762 | |
| 0.044 | 0.109 | 0.128 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.1 0.037 DBMET03760 0.128 0.026 DBMET03762 | DBMET03762 | |
| 0.045 | 0.11 | 0.111 | Histamine H1 receptor antagonist | 0.111 0.036 DBMET03760 0.082 0.055 DBMET03762 | DBMET03760 | |
| 0.01 | 0.076 | 0.024 | CC chemokine 1 receptor antagonist | 0.024 0.016 DBMET03760 | DBMET03760 | |
| 0.012 | 0.079 | 0.021 | Retinoid X beta receptor antagonist | 0.021 0.012 DBMET03762 | DBMET03762 | |
| 0.028 | 0.096 | 0.061 | Acyl-CoA dehydrogenase inhibitor | 0.058 0.034 DBMET03760 0.061 0.032 DBMET03762 | DBMET03762 | |
| 0.019 | 0.088 | 0.054 | Angiotensin II receptor antagonist | 0.039 0.016 DBMET03760 0.054 0.005 DBMET03762 | DBMET03762 | |
| 0.073 | 0.143 | 0.133 | Adenylate kinase inhibitor | 0.118 0.045 DBMET03760 0.133 0.034 DBMET03762 | DBMET03762 | |
| 0.045 | 0.115 | 0.077 | Epoxide hydrolase inhibitor | 0.077 0.045 DBMET03760 0.067 0.058 DBMET03762 | DBMET03760 | |
| 0.102 | 0.173 | 0.152 | Adenylate cyclase stimulant | 0.152 0.06 DBMET03760 0.15 0.063 DBMET03762 | DBMET03760 | |
| 0.054 | 0.126 | 0.148 | Aminopeptidase B inhibitor | 0.127 0.049 DBMET03760 0.148 0.038 DBMET03762 | DBMET03762 | |
| 0.038 | 0.11 | 0.117 | Phenylalanine 4-hydroxylase inhibitor | 0.099 0.026 DBMET03760 0.117 0.019 DBMET03762 | DBMET03762 | |
| 0.043 | 0.115 | 0.056 | Immunoglobulin Fc receptor antagonist | 0.056 0.036 DBMET03760 | DBMET03760 | |
| 0.024 | 0.096 | 0.065 | Aromatase inhibitor | 0.065 0.038 DBMET03760 | DBMET03760 | |
| 0.027 | 0.1 | 0.037 | Vanilloid 3 antagonist | 0.037 0.03 DBMET03760 | DBMET03760 | |
| 0.032 | 0.106 | 0.06 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.06 0.034 DBMET03760 0.054 0.042 DBMET03762 | DBMET03760 | |
| 0.028 | 0.102 | 0.049 | GABA B receptor antagonist | 0.049 0.021 DBMET03760 0.047 0.024 DBMET03762 | DBMET03760 | |
| 0.012 | 0.088 | 0.063 | Kainate receptor 2 antagonist | 0.051 0.016 DBMET03760 0.063 0.011 DBMET03762 | DBMET03762 | |
| 0.005 | 0.081 | 0.021 | Angiotensin AT1A receptor antagonist | 0.021 0.017 DBMET03760 | DBMET03760 | |
| 0.02 | 0.097 | 0.049 | Glutamate (mGluR group I) agonist | 0.049 0.031 DBMET03760 | DBMET03760 | |
| 0.014 | 0.091 | 0.033 | Methionyl aminopeptidase 1 inhibitor | 0.033 0.021 DBMET03760 | DBMET03760 | |
| 0.036 | 0.114 | 0.066 | Dopamine D1 antagonist | 0.066 0.044 DBMET03760 | DBMET03760 | |
| 0.036 | 0.115 | 0.086 | Alpha adrenoreceptor agonist | 0.086 0.034 DBMET03760 | DBMET03760 | |
| 0.021 | 0.102 | 0.053 | Geranyltranstransferase inhibitor | 0.053 0.02 DBMET03760 | DBMET03760 | |
| 0.036 | 0.118 | 0.162 | Catalase inhibitor | 0.119 0.033 DBMET03760 0.162 0.023 DBMET03762 | DBMET03762 | |
| 0.067 | 0.15 | 0.115 | Beta glucuronidase inhibitor | 0.115 0.05 DBMET03760 0.09 0.088 DBMET03762 | DBMET03760 | |
| 0.012 | 0.096 | 0.026 | Nicotinic acid receptor 2 antagonist | 0.026 0.019 DBMET03760 | DBMET03760 | |
| 0.087 | 0.171 | 0.177 | Diuretic | 0.177 0.056 DBMET03760 0.173 0.058 DBMET03762 | DBMET03760 | |
| 0.014 | 0.097 | 0.074 | Kainate receptor antagonist | 0.059 0.016 DBMET03760 0.074 0.011 DBMET03762 | DBMET03762 | |
| 0.017 | 0.101 | 0.027 | Estrogen-related receptor gamma antagonist | 0.027 0.023 DBMET03760 | DBMET03760 | |
| 0.14 | 0.224 | 0.298 | 12-Lipoxygenase inhibitor | 0.298 0.08 DBMET03760 0.227 0.124 DBMET03762 | DBMET03760 | |
| 0.074 | 0.16 | 0.124 | TRPA1 agonist | 0.124 0.054 DBMET03760 0.115 0.064 DBMET03762 | DBMET03760 | |
| 0.009 | 0.095 | 0.028 | CXC chemokine 2 receptor antagonist | 0.028 0.017 DBMET03760 | DBMET03760 | |
| 0.018 | 0.104 | 0.072 | NMDA 2A receptor antagonist | 0.072 0.023 DBMET03760 0.066 0.026 DBMET03762 | DBMET03760 | |
| 0.066 | 0.153 | 0.112 | Carbonic anhydrase XV inhibitor | 0.112 0.053 DBMET03760 | DBMET03760 | |
| 0.073 | 0.161 | 0.112 | Calcium channel N-type blocker | 0.112 0.075 DBMET03760 | DBMET03760 | |
| 0.019 | 0.107 | 0.031 | Carboxypeptidase B inhibitor | 0.031 0.026 DBMET03762 | DBMET03762 | |
| 0.013 | 0.102 | 0.022 | ICAM 1 antagonist | 0.022 0.018 DBMET03760 0.022 0.017 DBMET03762 | DBMET03762 | |
| 0.026 | 0.115 | 0.077 | Argininosuccinate synthase inhibitor | 0.059 0.038 DBMET03760 0.077 0.026 DBMET03762 | DBMET03762 | |
| 0.014 | 0.103 | 0.045 | Retinoid X alpha receptor agonist | 0.034 0.025 DBMET03760 0.045 0.017 DBMET03762 | DBMET03762 | |
| 0.03 | 0.119 | 0.09 | Factor IXa inhibitor | 0.09 0.013 DBMET03760 0.067 0.022 DBMET03762 | DBMET03760 | |
| 0.004 | 0.095 | 0.027 | Kainate receptor 1 antagonist | 0.018 0.017 DBMET03760 0.027 0.011 DBMET03762 | DBMET03762 | |
| 0.016 | 0.108 | 0.043 | Glycine transporter inhibitor | 0.043 0.037 DBMET03760 | DBMET03760 | |
| 0.061 | 0.153 | 0.149 | ABCA1 expression enhancer | 0.142 0.019 DBMET03760 0.149 0.017 DBMET03762 | DBMET03762 | |
| 0.029 | 0.122 | 0.046 | Dopamine beta hydroxylase inhibitor | 0.046 0.04 DBMET03760 | DBMET03760 | |
| 0.038 | 0.131 | 0.104 | Glutamate decarboxylase inhibitor | 0.082 0.042 DBMET03760 0.104 0.028 DBMET03762 | DBMET03762 | |
| 0.053 | 0.146 | 0.097 | Sphingosine 1-phosphate receptor antagonist | 0.097 0.024 DBMET03760 0.091 0.029 DBMET03762 | DBMET03760 | |
| 0.006 | 0.1 | 0.021 | Prostaglandin EP2 agonist | 0.021 0.017 DBMET03762 | DBMET03762 | |
| 0.022 | 0.116 | 0.048 | Dihydroorotase inhibitor | 0.048 0.026 DBMET03760 | DBMET03760 | |
| 0.025 | 0.119 | 0.09 | Alcohol oxidase inhibitor | 0.069 0.029 DBMET03760 0.09 0.021 DBMET03762 | DBMET03762 | |
| 0.034 | 0.128 | 0.083 | Cannabinoid receptor antagonist | 0.083 0.038 DBMET03760 | DBMET03760 | |
| 0.042 | 0.136 | 0.079 | Calcium channel L-type blocker | 0.079 0.041 DBMET03760 | DBMET03760 | |
| 0.041 | 0.136 | 0.059 | Leukotriene C antagonist | 0.055 0.042 DBMET03760 0.059 0.033 DBMET03762 | DBMET03762 | |
| 0.036 | 0.132 | 0.069 | Na+ K+ transporting ATPase inhibitor | 0.069 0.061 DBMET03760 | DBMET03760 | |
| 0.06 | 0.157 | 0.081 | Granulocyte macrophage colony stimulating factor agonist | 0.081 0.072 DBMET03760 | DBMET03760 | |
| 0.102 | 0.199 | 0.15 | MAP kinase 3 inhibitor | 0.15 0.068 DBMET03760 | DBMET03760 | |
| 0.072 | 0.169 | 0.141 | Sodium channel (voltage-gated) blocker | 0.141 0.062 DBMET03760 | DBMET03760 | |
| 0.027 | 0.124 | 0.059 | Acetylcholine M5 receptor antagonist | 0.059 0.043 DBMET03760 | DBMET03760 | |
| 0.027 | 0.124 | 0.038 | Leukotriene C4 antagonist | 0.038 0.029 DBMET03762 | DBMET03762 | |
| 0.021 | 0.118 | 0.031 | Protein kinase (CK2) beta inhibitor | 0.031 0.029 DBMET03760 | DBMET03760 | |
| 0.073 | 0.171 | 0.15 | Alkaline phosphatase inhibitor | 0.15 0.06 DBMET03760 0.121 0.085 DBMET03762 | DBMET03760 | |
| 0.128 | 0.228 | 0.245 | Superoxide dismutase inhibitor | 0.244 0.079 DBMET03760 0.245 0.078 DBMET03762 | DBMET03762 | |
| 0.031 | 0.131 | 0.062 | Sphingosine kinase 2 inhibitor | 0.062 0.03 DBMET03760 | DBMET03760 | |
| 0.026 | 0.127 | 0.056 | CC chemokine 2 receptor antagonist | 0.056 0.036 DBMET03760 | DBMET03760 | |
| 0.084 | 0.187 | 0.331 | Psychostimulant | 0.245 0.06 DBMET03760 0.331 0.035 DBMET03762 | DBMET03762 | |
| 0.016 | 0.121 | 0.061 | Phosphorylase inhibitor | 0.058 0.026 DBMET03760 0.061 0.024 DBMET03762 | DBMET03762 | |
| 0.047 | 0.155 | 0.112 | Urease inhibitor | 0.112 0.053 DBMET03760 | DBMET03760 | |
| 0.006 | 0.115 | 0.037 | Arginase inhibitor | 0.037 0.025 DBMET03762 | DBMET03762 | |
| 0.005 | 0.114 | 0.021 | Prostaglandin E2 agonist | 0.021 0.02 DBMET03762 | DBMET03762 | |
| 0.016 | 0.127 | 0.043 | Guanylate cyclase inhibitor | 0.043 0.03 DBMET03760 | DBMET03760 | |
| 0.02 | 0.131 | 0.044 | AMPA 4 receptor antagonist | 0.04 0.027 DBMET03760 0.044 0.02 DBMET03762 | DBMET03762 | |
| 0.059 | 0.173 | 0.19 | Amylase inhibitor | 0.19 0.048 DBMET03760 0.184 0.05 DBMET03762 | DBMET03760 | |
| 0.016 | 0.129 | 0.052 | Ornithine carbamoyltransferase inhibitor | 0.052 0.038 DBMET03762 | DBMET03762 | |
| 0.04 | 0.153 | 0.145 | Potassium channel (Ca-activated) activator | 0.145 0.03 DBMET03760 0.132 0.035 DBMET03762 | DBMET03760 | |
| 0.031 | 0.145 | 0.103 | Histidine decarboxylase inhibitor | 0.082 0.041 DBMET03760 0.103 0.03 DBMET03762 | DBMET03762 | |
| 0.004 | 0.119 | 0.029 | Free fatty acid receptor 1 agonist | 0.016 0.014 DBMET03760 0.029 0.006 DBMET03762 | DBMET03762 | |
| 0.013 | 0.127 | 0.034 | Carnitine palmitoyltransferase 1 inhibitor | 0.032 0.028 DBMET03760 0.034 0.024 DBMET03762 | DBMET03762 | |
| 0.054 | 0.168 | 0.086 | Alpha 2c adrenoreceptor antagonist | 0.086 0.08 DBMET03760 | DBMET03760 | |
| 0.032 | 0.146 | 0.121 | Porphobilinogen synthase inhibitor | 0.089 0.041 DBMET03760 0.121 0.028 DBMET03762 | DBMET03762 | |
| 0.058 | 0.176 | 0.153 | Glutamate receptor antagonist | 0.153 0.049 DBMET03760 0.102 0.094 DBMET03762 | DBMET03760 | |
| 0.009 | 0.126 | 0.029 | Prostaglandin agonist | 0.029 0.023 DBMET03762 | DBMET03762 | |
| 0.084 | 0.203 | 0.188 | Hexokinase inhibitor | 0.188 0.043 DBMET03760 0.161 0.067 DBMET03762 | DBMET03760 | |
| 0.044 | 0.165 | 0.064 | Beta 2 adrenoreceptor agonist | 0.064 0.034 DBMET03760 | DBMET03760 | |
| 0.011 | 0.132 | 0.033 | Carnitine palmitoyltransferase inhibitor | 0.031 0.029 DBMET03760 0.033 0.024 DBMET03762 | DBMET03762 | |
| 0.031 | 0.153 | 0.049 | CD45 antagonist | 0.049 0.038 DBMET03762 | DBMET03762 | |
| 0.011 | 0.132 | 0.047 | Urate transporter 1 inhibitor | 0.038 0.028 DBMET03760 0.047 0.02 DBMET03762 | DBMET03762 | |
| 0.026 | 0.149 | 0.052 | Lysine-specific demethylase 1A inhibitor | 0.052 0.041 DBMET03760 | DBMET03760 | |
| 0.059 | 0.185 | 0.131 | Mucolytic | 0.116 0.058 DBMET03760 0.131 0.045 DBMET03762 | DBMET03762 | |
| 0.026 | 0.153 | 0.055 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.055 0.045 DBMET03760 0.053 0.048 DBMET03762 | DBMET03760 | |
| 0.086 | 0.212 | 0.122 | Vanilloid 1 agonist | 0.121 0.085 DBMET03760 0.122 0.083 DBMET03762 | DBMET03762 | |
| 0.019 | 0.148 | 0.061 | Purinergic P2X antagonist | 0.061 0.022 DBMET03760 | DBMET03760 | |
| 0.003 | 0.133 | 0.015 | Integrin alpha4beta1 antagonist | 0.015 0.012 DBMET03762 | DBMET03762 | |
| 0.017 | 0.148 | 0.066 | NMDA 2C receptor antagonist | 0.066 0.038 DBMET03760 0.061 0.044 DBMET03762 | DBMET03760 | |
| 0.039 | 0.172 | 0.06 | Phosphodiesterase 1C inhibitor | 0.06 0.049 DBMET03760 | DBMET03760 | |
| 0.062 | 0.197 | 0.134 | Sodium channel blocker | 0.134 0.07 DBMET03760 | DBMET03760 | |
| 0.054 | 0.19 | 0.099 | Carbonic anhydrase III inhibitor | 0.099 0.063 DBMET03760 0.093 0.071 DBMET03762 | DBMET03760 | |
| 0.064 | 0.202 | 0.1 | Nav1.5 sodium channel blocker | 0.1 0.084 DBMET03760 | DBMET03760 | |
| 0.008 | 0.146 | 0.031 | Retinoid X receptor agonist | 0.031 0.029 DBMET03762 | DBMET03762 | |
| 0.037 | 0.176 | 0.065 | Beta 3 adrenoreceptor antagonist | 0.065 0.043 DBMET03760 | DBMET03760 | |
| 0.019 | 0.158 | 0.048 | CC chemokine 5 receptor antagonist | 0.048 0.039 DBMET03760 | DBMET03760 | |
| 0.017 | 0.157 | 0.052 | Dihydroorotate dehydrogenase inhibitor | 0.052 0.035 DBMET03760 | DBMET03760 | |
| 0.047 | 0.19 | 0.071 | Estrogen receptor alpha antagonist | 0.071 0.066 DBMET03760 | DBMET03760 | |
| 0.117 | 0.26 | 0.187 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.187 0.084 DBMET03760 0.176 0.099 DBMET03762 | DBMET03760 | |
| 0.027 | 0.172 | 0.051 | Heparanase inhibitor | 0.051 0.042 DBMET03762 | DBMET03762 | |
| 0.13 | 0.277 | 0.283 | Vasodilator, coronary | 0.283 0.102 DBMET03760 0.256 0.128 DBMET03762 | DBMET03760 | |
| 0.106 | 0.257 | 0.169 | Neurotensin receptor agonist | 0.16 0.079 DBMET03760 0.169 0.064 DBMET03762 | DBMET03762 | |
| 0.023 | 0.182 | 0.066 | Leukotriene B4 antagonist | 0.066 0.022 DBMET03762 | DBMET03762 | |
| 0.104 | 0.264 | 0.245 | Cyclic AMP phosphodiesterase inhibitor | 0.212 0.085 DBMET03760 0.245 0.066 DBMET03762 | DBMET03762 | |
| 0.04 | 0.2 | 0.09 | Peroxisome proliferator-activated receptor gamma antagonist | 0.069 0.055 DBMET03760 0.09 0.023 DBMET03762 | DBMET03762 | |
| 0.049 | 0.21 | 0.115 | Estrogen receptor beta antagonist | 0.115 0.039 DBMET03760 0.093 0.078 DBMET03762 | DBMET03760 | |
| 0.036 | 0.198 | 0.109 | Adrenaline agonist | 0.109 0.031 DBMET03760 | DBMET03760 | |
| 0.067 | 0.231 | 0.131 | Protein kinase stimulant | 0.131 0.083 DBMET03760 0.125 0.087 DBMET03762 | DBMET03760 | |
| 0.07 | 0.236 | 0.172 | Cell wall synthesis inhibitor | 0.172 0.045 DBMET03760 0.166 0.051 DBMET03762 | DBMET03760 | |
| 0.009 | 0.176 | 0.033 | Nicotinic acid receptor agonist | 0.033 0.03 DBMET03760 | DBMET03760 | |
| 0.05 | 0.217 | 0.121 | Nav1.6 sodium channel blocker | 0.121 0.095 DBMET03760 | DBMET03760 | |
| 0.02 | 0.196 | 0.055 | Carnitine palmitoyltransferase 1B inhibitor | 0.047 0.034 DBMET03760 0.055 0.022 DBMET03762 | DBMET03762 | |
| 0.027 | 0.203 | 0.054 | Sphingosine 1-phosphate receptor 1 antagonist | 0.054 0.042 DBMET03760 0.053 0.045 DBMET03762 | DBMET03760 | |
| 0.015 | 0.196 | 0.05 | p53 inhibitor | 0.039 0.021 DBMET03760 0.05 0.014 DBMET03762 | DBMET03762 | |
| 0.029 | 0.212 | 0.051 | Glucosylceramidase inhibitor | 0.051 0.047 DBMET03760 | DBMET03760 | |
| 0.038 | 0.222 | 0.102 | Expectorant | 0.089 0.082 DBMET03760 0.102 0.066 DBMET03762 | DBMET03762 | |
| 0.02 | 0.205 | 0.1 | Leukotriene antagonist | 0.1 0.022 DBMET03762 | DBMET03762 | |
| 0.083 | 0.274 | 0.136 | CF transmembrane conductance regulator agonist | 0.136 0.104 DBMET03760 | DBMET03760 | |
| 0.058 | 0.266 | 0.136 | Acetylcholine M1 receptor antagonist | 0.133 0.092 DBMET03760 0.136 0.089 DBMET03762 | DBMET03762 | |
| 0.052 | 0.268 | 0.103 | Toll-Like receptor 2 antagonist | 0.103 0.1 DBMET03762 | DBMET03762 | |
| 0.101 | 0.321 | 0.238 | Gastrin inhibitor | 0.23 0.105 DBMET03760 0.238 0.093 DBMET03762 | DBMET03762 | |
| 0.04 | 0.266 | 0.103 | Acetylcholine muscarinic antagonist | 0.103 0.088 DBMET03762 | DBMET03762 | |
| 0.162 | 0.39 | 0.31 | Caspase 9 stimulant | 0.31 0.183 DBMET03760 0.28 0.216 DBMET03762 | DBMET03760 | |
| 0.009 | 0.244 | 0.063 | NMDA 2 receptor antagonist | 0.063 0.059 DBMET03760 | DBMET03760 | |
| 0.113 | 0.35 | 0.222 | Insulysin inhibitor | 0.211 0.141 DBMET03760 0.222 0.127 DBMET03762 | DBMET03762 | |
| 0.099 | 0.35 | 0.285 | Antithrombotic | 0.258 0.12 DBMET03760 0.285 0.099 DBMET03762 | DBMET03762 | |
| 0.026 | 0.284 | 0.085 | Alcohol dehydrogenase inhibitor | 0.085 0.072 DBMET03762 | DBMET03762 | |
| 0.061 | 0.322 | 0.301 | Spasmolytic | 0.224 0.103 DBMET03760 0.301 0.069 DBMET03762 | DBMET03762 | |
| 0.057 | 0.331 | 0.196 | Interleukin agonist | 0.187 0.133 DBMET03760 0.196 0.124 DBMET03762 | DBMET03762 | |
| 0.028 | 0.305 | 0.079 | Potassium channel large-conductance Ca-activated activator | 0.079 0.036 DBMET03760 0.072 0.042 DBMET03762 | DBMET03760 | |
| 0.046 | 0.323 | 0.169 | Phospholipase A2 inhibitor | 0.122 0.114 DBMET03760 0.169 0.06 DBMET03762 | DBMET03762 | |
| 0.003 | 0.292 | 0.091 | VLA-4 antagonist | 0.091 0.007 DBMET03762 | DBMET03762 | |
| 0.02 | 0.317 | 0.041 | Integrin alpha1beta1 antagonist | 0.041 0.018 DBMET03762 | DBMET03762 | |
| 0.033 | 0.339 | 0.103 | Caspase 3 inhibitor | 0.103 0.087 DBMET03762 | DBMET03762 | |
| 0.041 | 0.353 | 0.118 | Estrogen antagonist | 0.118 0.059 DBMET03760 0.1 0.098 DBMET03762 | DBMET03760 | |
| 0.071 | 0.386 | 0.282 | Transcription factor NF kappa B inhibitor | 0.229 0.143 DBMET03760 0.282 0.105 DBMET03762 | DBMET03762 | |
| 0.046 | 0.363 | 0.154 | Immunostimulant | 0.154 0.151 DBMET03762 | DBMET03762 | |
| 0.087 | 0.404 | 0.222 | Vasodilator, peripheral | 0.222 0.152 DBMET03760 0.211 0.163 DBMET03762 | DBMET03760 | |
| 0.003 | 0.339 | 0.075 | Endothelin B receptor antagonist | 0.075 0.005 DBMET03762 | DBMET03762 | |
| 0.003 | 0.35 | 0.022 | Integrin alpha4beta7 antagonist | 0.022 0.013 DBMET03762 | DBMET03762 | |
| 0.067 | 0.413 | 0.186 | DNA synthesis inhibitor | 0.186 0.144 DBMET03760 0.178 0.157 DBMET03762 | DBMET03760 | |
| 0.026 | 0.375 | 0.054 | Adenine nucleotide translocase inhibitor | 0.054 0.043 DBMET03762 | DBMET03762 | |
| 0.069 | 0.419 | 0.208 | Transcription factor STAT inhibitor | 0.208 0.127 DBMET03760 | DBMET03760 | |
| 0.065 | 0.423 | 0.182 | Transcription factor STAT3 inhibitor | 0.182 0.161 DBMET03760 | DBMET03760 | |
| 0.056 | 0.422 | 0.23 | Lipoxygenase inhibitor | 0.23 0.114 DBMET03762 | DBMET03762 | |
| 0.038 | 0.405 | 0.156 | Insulin sensitizer | 0.156 0.126 DBMET03762 | DBMET03762 | |
| 0.012 | 0.389 | 0.065 | HIV-1 reverse transcriptase inhibitor | 0.065 0.054 DBMET03760 | DBMET03760 | |
| 0.028 | 0.407 | 0.089 | DNA directed RNA polymerase inhibitor | 0.089 0.07 DBMET03760 | DBMET03760 | |
| 0.016 | 0.395 | 0.075 | Topoisomerase II alpha inhibitor | 0.075 0.057 DBMET03761 | DBMET03761 | |
| 0.012 | 0.405 | 0.295 | Leukotriene synthesis inhibitor | 0.06 0.055 DBMET03760 0.295 0.004 DBMET03762 | DBMET03762 | |
| 0.036 | 0.441 | 0.296 | Interleukin antagonist | 0.296 0.049 DBMET03760 0.247 0.063 DBMET03762 | DBMET03760 | |
| 0.005 | 0.433 | 0.111 | Prostaglandin antagonist | 0.052 0.038 DBMET03760 0.111 0.015 DBMET03762 | DBMET03762 | |
| 0.01 | 0.445 | 0.039 | VCAM antagonist | 0.039 0.03 DBMET03762 | DBMET03762 | |
| 0.008 | 0.446 | 0.055 | Purinergic P2 antagonist | 0.055 0.053 DBMET03760 | DBMET03760 | |
| 0.01 | 0.449 | 0.039 | VCAM-1 antagonist | 0.039 0.03 DBMET03762 | DBMET03762 | |
| 0.003 | 0.443 | 0.07 | Integrin alpha4 antagonist | 0.07 0.009 DBMET03762 | DBMET03762 | |
| 0.028 | 0.522 | 0.079 | Interleukin 5 antagonist | 0.079 0.076 DBMET03760 | DBMET03760 | |
| 0.021 | 0.526 | 0.173 | Anticonvulsant | 0.173 0.105 DBMET03762 | DBMET03762 | |
| 0.012 | 0.534 | 0.061 | Prostaglandin F2 alpha antagonist | 0.061 0.045 DBMET03762 | DBMET03762 | |
| 0.004 | 0.53 | 0.037 | Prostacyclin antagonist | 0.037 0.02 DBMET03762 | DBMET03762 | |
| 0.025 | 0.557 | 0.099 | Toll-Like receptor 4 antagonist | 0.099 0.072 DBMET03762 | DBMET03762 | |
| 0.024 | 0.564 | 0.119 | Farnesoid X receptor antagonist | 0.118 0.108 DBMET03760 0.119 0.105 DBMET03762 | DBMET03762 | |
| 0.017 | 0.564 | 0.147 | Cyclooxygenase inhibitor | 0.147 0.072 DBMET03762 | DBMET03762 | |
| 0.018 | 0.571 | 0.093 | Chymotrypsin inhibitor | 0.093 0.041 DBMET03761 | DBMET03761 | |
| 0.019 | 0.573 | 0.068 | DNA helicase inhibitor | 0.068 0.018 DBMET03762 | DBMET03762 | |
| 0.003 | 0.572 | 0.019 | Endothelin A receptor antagonist | 0.019 0.018 DBMET03762 | DBMET03762 | |
| 0.003 | 0.586 | 0.028 | Prostaglandin D2 antagonist | 0.028 0.012 DBMET03762 | DBMET03762 | |
| 0.003 | 0.595 | 0.064 | Endothelin receptor antagonist | 0.064 0.008 DBMET03762 | DBMET03762 | |
| 0.003 | 0.615 | 0.092 | Leukotriene B4 receptor 1 antagonist | 0.092 0.004 DBMET03762 | DBMET03762 | |
| 0.008 | 0.621 | 0.056 | Sphingosine 1-phosphate receptor 5 agonist | 0.056 0.032 DBMET03762 | DBMET03762 | |
| 0.003 | 0.619 | 0.053 | Leukotriene B4 receptor 2 antagonist | 0.053 0.004 DBMET03762 | DBMET03762 | |
| 0.006 | 0.637 | 0.222 | 5-Lipoxygenase inhibitor | 0.222 0.02 DBMET03762 | DBMET03762 | |
| 0.017 | 0.648 | 0.136 | Amyloid beta precursor protein antagonist | 0.136 0.118 DBMET03760 | DBMET03760 | |
| 0.037 | 0.671 | 0.265 | Analgesic | 0.265 0.17 DBMET03760 | DBMET03760 | |
| 0.012 | 0.681 | 0.34 | Hypolipemic | 0.34 0.038 DBMET03762 | DBMET03762 | |
| 0.004 | 0.713 | 0.077 | Integrin antagonist | 0.077 0.02 DBMET03762 | DBMET03762 | |
| 0.061 | 0.8 | 0.133 | CC chemokine 6 receptor antagonist | 0.133 0.06 DBMET03761 | DBMET03761 | |
| 0.006 | 0.747 | 0.087 | Cell adhesion molecule inhibitor | 0.087 0.045 DBMET03762 | DBMET03762 | |
| 0.048 | 0.835 | 0.26 | Interleukin 2 agonist | 0.26 0.108 DBMET03762 | DBMET03762 | |
| 0.005 | 0.833 | 0.173 | Anticoagulant | 0.173 0.064 DBMET03762 | DBMET03762 | |
| 0.008 | 0.838 | 0.134 | Cell adhesion inhibitor | 0.134 0.056 DBMET03762 | DBMET03762 | |
| 0.018 | 0.903 | 0.236 | Apoptosis antagonist | 0.236 0.141 DBMET03762 | DBMET03762 | |
| 0.009 | 0.908 | 0.495 | Antiinflammatory | 0.29 0.225 DBMET03760 0.495 0.09 DBMET03762 | DBMET03762 | |
| 0.007 | 0.908 | 0.131 | Insulin secretagoues | 0.131 0.095 DBMET03762 | DBMET03762 | |
| 0.005 | 0.924 | 0.655 | Toll-Like receptor 7 agonist | 0.655 0.012 DBMET03762 | DBMET03762 | |
| 0.005 | 0.931 | 0.647 | Toll-Like receptor agonist | 0.647 0.013 DBMET03762 | DBMET03762 | |
| 0.007 | 0.936 | 0.182 | Hypoglycemic | 0.182 0.131 DBMET03762 0.176 0.138 DBMET03761 | DBMET03762 | |
| 0.005 | 0.961 | 0.119 | Thrombolytic | 0.119 0.112 DBMET03762 | DBMET03762 | |
| 0.004 | 0.987 | 0.238 | Antioxidant | 0.238 0.09 DBMET03762 | DBMET03762 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |